{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T17:18:31Z","timestamp":1713806311049},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2004,11,1]],"date-time":"2004-11-01T00:00:00Z","timestamp":1099267200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2004,11]]},"DOI":"10.1007\/s00108-004-1287-3","type":"journal-article","created":{"date-parts":[[2004,10,15]],"date-time":"2004-10-15T13:27:17Z","timestamp":1097846837000},"page":"1261-1267","source":"Crossref","is-referenced-by-count":5,"title":["Knochenmarktransplantation"],"prefix":"10.1007","volume":"45","author":[{"given":"B.","family":"Hertenstein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Ganser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1007\/s00277-001-0384-9","volume":"80","author":"Ottinger","year":"2001","unstructured":"Ottinger HD, Muller CR, Goldmann SF et al. (2001) Second German consensus on immunogenetic donor search for allotransplantation of hematopoietic stem cells. Ann Hematol 80: 706?714","journal-title":"Ann Hematol"},{"key":"CR2","unstructured":"http:\/\/www.bmdw.org"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1056\/NEJM199810223391702","volume":"339","author":"Aversa","year":"1998","unstructured":"Aversa F, Tabilio A, Velardi A et al. (1998) Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype. N Engl J Med 339: 1186?1193","journal-title":"N Engl J Med"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1200\/JCO.2000.18.3.537","volume":"18","author":"Blaise","year":"2000","unstructured":"Blaise D, Kuentz M, Fortanier C et al. (2000) Randomized trial of bone marrow versus lenograstim-primed blood cell allogeneic transplantation in patients with early-stage leukemia: a report from the Societe Francaise de Greffe de Moelle. J Clin Oncol 18: 537?546","journal-title":"J Clin Oncol"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1056\/NEJM200101183440303","volume":"344","author":"Bensinger","year":"2001","unstructured":"Bensinger WI, Martin PJ, Storer B et al. (2001) Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers. N Engl J Med 344: 175?181","journal-title":"N Engl J Med"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1182\/blood-2001-12-0304","volume":"100","author":"Schmitz","year":"2002","unstructured":"Schmitz N, Beksac M, Hasenclever D et al. (2002) European Group for Blood and Marrow Transplantation. Transplantation of mobilized peripheral blood cells to HLA-identical siblings with standard-risk leukemia. Blood 100: 761?767","journal-title":"Blood"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1053\/j.seminoncol.2003.10.015","volume":"31","author":"Slavin","year":"2004","unstructured":"Slavin S (2004) Reduced-intensity conditioning or nonmyeloablative stem cell transplantation: introduction, rationale, and historic background. Semin Oncol 31: 1?3","journal-title":"Semin Oncol"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1182\/blood-2002-05-1340","volume":"101","author":"Niederwieser","year":"2003","unstructured":"Niederwieser D, Maris M, Shizuru JA et al. (2003) Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce durable complete chimerism and sustained remissions in patients with hematological diseases. Blood 101: 1620?1629","journal-title":"Blood"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1182\/blood.V86.5.2041.bloodjournal8652041","volume":"86","author":"Kolb","year":"1995","unstructured":"Kolb HJ, Schattenberg A, Goldman JM et al. (1995) D Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia. Blood 86: 2041?2050","journal-title":"Blood"},{"key":"CR10","unstructured":"http:\/\/www.drst.de"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1056\/NEJM199607113350204","volume":"335","author":"Attal","year":"1996","unstructured":"Attal M, Harousseau JL, Stoppa AM et al. (1996) A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. N Engl J Med 335: 91?97","journal-title":"N Engl J Med"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1056\/NEJMoa032290","volume":"349","author":"Attal","year":"2003","unstructured":"Attal M, Harousseau JL, Facon T et al.; InterGroupe Francophone du Myelome (2003) Single versus double autologous stem-cell transplantation for multiple myeloma. N Engl J Med 349: 2495?2502","journal-title":"N Engl J Med"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1056\/NEJM199512073332305","volume":"333","author":"Philip","year":"1995","unstructured":"Philip T, Guglielmi C, Somers R et al. (1995) Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin?s lymphoma. N Engl J Med 333: 1540?1545","journal-title":"N Engl J Med"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1200\/JCO.2004.07.130","volume":"22","author":"Kiehl","year":"2004","unstructured":"Kiehl MG, Kraut L, Schwerdtfeger R et al. (2004) Outcome of allogeneic hematopoietic stem-cell transplantation in adult patients with acute lymphoblastic leukemia: no difference in related compared with unrelated transplant in first complete remission. J Clin Oncol 22: 2816?2825","journal-title":"J Clin Oncol"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1182\/blood-2004-01-0338","volume":"104","author":"Cutler","year":"2004","unstructured":"Cutler CS, Lee SJ, Greenberg P et al. (2004) A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved outcome. Blood 104: 579?585","journal-title":"Blood"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1182\/blood-2002-01-0131","volume":"100","author":"Kroger","year":"2002","unstructured":"Kroger N, Schwerdtfeger R, Kiehl M et al. (2002) Autologous stem cell transplantation followed by a dose-reduced allograft induces high complete remission rate in multiple myeloma. Blood 100: 755?760","journal-title":"Blood"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1073\/pnas.0530192100","volume":"100","author":"Marijt","year":"2003","unstructured":"Marijt WA, Heemskerk MH, Kloosterboer FM et al. (2003) Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemia. Proc Natl Acad Sci U S A 100: 2742?2747","journal-title":"Proc Natl Acad Sci U S A"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1182\/blood.V98.3.565","volume":"98","author":"Bunjes","year":"2001","unstructured":"Bunjes D, Buchmann I, Duncker C et al. (2001) Rhenium 188-labeled anti-CD66 (a, b, c, e) monoclonal antibody to intensify the conditioning regimen prior to stem cell transplantation for patients with high-risk acute myeloid leukemia or myelodysplastic syndrome: results of a phase I?II study. Blood 98: 565?572","journal-title":"Blood"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"3565","DOI":"10.1182\/blood-2003-09-3056","volume":"103","author":"Rauser","year":"2004","unstructured":"Rauser G, Einsele H, Sinzger C et al. (2004) Rapid generation of combined CMV-specific CD4+ and CD8+ T-cell lines for adoptive transfer into recipients of allogeneic stem cell transplants. Blood 103: 3565?3572","journal-title":"Blood"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1182\/blood-2004-02-0518","volume":"104","author":"Kaiser","year":"2004","unstructured":"Kaiser T, Kamal H, Rank A et al. (2004) Proteomics applied to the clinical follow-up of patients after allogeneic hematopoietic stem cell transplantation. Blood 104: 340?349","journal-title":"Blood"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1182\/blood-2002-08-2351","volume":"101","author":"Marktel","year":"2003","unstructured":"Marktel S, Magnani Z, Ciceri F et al. (2003) Immunologic potential of donor lymphocytes expressing a suicide gene for early immune reconstitution after hematopoietic T-cell-depleted stem cell transplantation. Blood 101: 1290?1298","journal-title":"Blood"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0140-6736(04)16626-9","volume":"364","author":"Wollert","year":"2004","unstructured":"Wollert KC, Meyer GP, Lotz J et al. (2004) Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 364: 141?148","journal-title":"Lancet"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-004-1287-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00108-004-1287-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-004-1287-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T10:38:52Z","timestamp":1585910332000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00108-004-1287-3"}},"subtitle":["Indikationen, Chancen und Perspektiven"],"short-title":[],"issued":{"date-parts":[[2004,11]]},"references-count":22,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2004,11]]}},"alternative-id":["1287"],"URL":"https:\/\/doi.org\/10.1007\/s00108-004-1287-3","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,11]]}}}